Literature DB >> 15187145

Rac1 and Toll-IL-1 receptor domain-containing adapter protein mediate Toll-like receptor 4 induction of HIV-long terminal repeat.

Ozlem Equils1, Zeynep Madak, Chunrin Liu, Kathrin S Michelsen, Yonca Bulut, Daning Lu.   

Abstract

Opportunistic infections, common in HIV-1-infected patients, increase HIV replication; however, the intracellular signaling mechanisms involved are not clearly known. We have shown that Toll-like receptor 2 (TLR2), TLR4, and TLR9 mediate microbial Ag-induced HIV-long terminal repeat (HIV-LTR) trans-activation and HIV-1 replication, and that LPS-induced HIV-LTR trans-activation is mediated through myeloid differentiation adapter protein. Recently, Toll-IL-1R domain-containing adapter protein (TIRAP) has been identified as an adapter molecule that mediates responses to TLR2 and TLR4 ligands, and TIRAP was suggested to provide signaling specificity for different TLRs. Rac1, a small GTP-binding protein that is activated upon LPS stimulation of macrophages, activates phosphatidylinositol 3-kinase and Akt and leads to NF-kappaB activation. The roles of Rac1 and TIRAP in LPS activation of HIV replication is not known. In the present study we show that LPS stimulation of human microvessel endothelial cells leads to Rac1 activation. Constitutively active Rac1 (Rac1V12) simulated the effect of LPS to activate HIV-LTR, whereas the expression of dominant negative Rac1 (Rac1N17) partially blocked LPS-induced HIV-LTR trans-activation. Rac1V12-induced HIV-LTR activation was independent of myeloid differentiation adapter protein, and dominant negative TIRAP blocked Rac1V12-induced HIV-LTR trans-activation. In this study we show for the first time that activation of Rac1 leads to HIV-LTR trans-activation, and this is mediated through TIRAP. Together these results underscore the importance of Rac1 and TIRAP in TLR4 activation of HIV replication and help delineate the signaling pathways induced by TLRs to mediate microbial Ag-induced HIV replication and HIV pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15187145     DOI: 10.4049/jimmunol.172.12.7642

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

Review 1.  New players in TLR-mediated innate immunity: PI3K and small Rho GTPases.

Authors:  Monica Ruse; Ulla G Knaus
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

Review 2.  Deconstructing innate immune signaling in myelodysplastic syndromes.

Authors:  Madeline Niederkorn; Molly Smith; Laura Barreyro; Melinda E Varney; Katelyn Melgar; Daniel T Starczynowski
Journal:  Exp Hematol       Date:  2015-07-02       Impact factor: 3.084

3.  HIV-1 reactivation induced by the periodontal pathogens Fusobacterium nucleatum and Porphyromonas gingivalis involves Toll-like receptor 2 [corrected] and 9 activation in monocytes/macrophages.

Authors:  Octavio A González; Mengtao Li; Jeffrey L Ebersole; Chifu B Huang
Journal:  Clin Vaccine Immunol       Date:  2010-07-07

Review 4.  Discovery of carboxyethylpyrroles (CEPs): critical insights into AMD, autism, cancer, and wound healing from basic research on the chemistry of oxidized phospholipids.

Authors:  Robert G Salomon; Li Hong; Joe G Hollyfield
Journal:  Chem Res Toxicol       Date:  2011-10-03       Impact factor: 3.739

Review 5.  Oral infectious diseases: a potential risk factor for HIV virus recrudescence?

Authors:  O A González; J L Ebersole; C B Huang
Journal:  Oral Dis       Date:  2009-04-02       Impact factor: 3.511

6.  Porphyromonas gingivalis-mediated signaling through TLR4 mediates persistent HIV infection of primary macrophages.

Authors:  Luis M Agosto; Juliane B Hirnet; Daniel H Michaels; Yazdani B Shaik-Dasthagirisaheb; Frank C Gibson; Gregory Viglianti; Andrew J Henderson
Journal:  Virology       Date:  2016-09-16       Impact factor: 3.616

7.  Gene-expression profiling of HIV-1 infection and perinatal transmission in Botswana.

Authors:  M Montano; M Rarick; P Sebastiani; P Brinkmann; M Russell; A Navis; C Wester; I Thior; M Essex
Journal:  Genes Immun       Date:  2006-05-04       Impact factor: 2.676

8.  The Rho-GEF Trio regulates a novel pro-inflammatory pathway through the transcription factor Ets2.

Authors:  Jos Van Rijssel; Ilse Timmerman; Floris P J Van Alphen; Mark Hoogenboezem; Olexandr Korchynskyi; Dirk Geerts; Judy Geissler; Kris A Reedquist; Hans W M Niessen; Jaap D Van Buul
Journal:  Biol Open       Date:  2013-04-16       Impact factor: 2.422

9.  GEF-H1 mediated control of NOD1 dependent NF-kappaB activation by Shigella effectors.

Authors:  Atsuko Fukazawa; Carmen Alonso; Kiyotaka Kurachi; Sonal Gupta; Cammie F Lesser; Beth Ann McCormick; Hans-Christian Reinecker
Journal:  PLoS Pathog       Date:  2008-11-28       Impact factor: 6.823

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.